Literature DB >> 1391727

Hypoechoic lesions in the 'bright liver': a reliable indicator of fatty change. A prospective study.

E Caturelli1, M M Squillante, A Andriulli, A Cedrone, C Cellerino, M Pompili, E R Manoja, G L Rapaccini.   

Abstract

The accuracy of ultrasonographic diagnosis of hypoechoic focal fatty change in the 'bright liver' was evaluated in 40 lesions found in 35 patients followed up for a mean period of 37.8 months. Patients with ultrasound and laboratory findings suggesting liver cirrhosis were excluded from the study. All patients underwent a blind liver biopsy in order to verify the diagnosis of diffuse disease suggested by the finding of 'bright liver'. No guided biopsy was performed on the focal lesions in order to establish the accuracy of ultrasound alone in recognizing focal fatty change. Clinical, haematologic and echographic follow-up confirmed the diagnosis in all cases. All histological specimens revealed liver steatosis, indicating a 100% sensitivity of ultrasonography in identifying non-cirrhotic fatty liver with an accompanying focal change. Increased echogenicity and hypoechoic focal changes are reliable indicators of fatty infiltration, making ultrasonography an acceptable, non-invasive method for the diagnosis of liver steatosis.

Entities:  

Mesh:

Year:  1992        PMID: 1391727     DOI: 10.1111/j.1440-1746.1992.tb01022.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  The utility of Xenon-133 liver scan in the diagnosis and management of nonalcoholic fatty liver disease.

Authors:  Said A Al-Busafi; Peter Ghali; Philip Wong; Javier A Novales-Diaz; Marc Deschênes
Journal:  Can J Gastroenterol       Date:  2012-03       Impact factor: 3.522

Review 2.  Practical management of the increasing burden of non-alcoholic fatty liver disease.

Authors:  Angelina Mouralidarane; Ching-I Lin; Narin Suleyman; Junpei Soeda; Jude A Oben
Journal:  Frontline Gastroenterol       Date:  2010-09-23

3.  Non-invasive means of measuring hepatic fat content.

Authors:  Sanjeev-R Mehta; E-Louise Thomas; Jimmy-D Bell; Desmond-G Johnston; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

4.  The prevalence of bright liver echo pattern in patients with chronic hepatitis C: correlation with steatosis and fibrosis.

Authors:  Maurizio Loy; Giancarlo Serra; Luchino Chessa
Journal:  J Ultrasound       Date:  2014-07-05

Review 5.  4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.

Authors:  Francesca Maria Trovato; Daniela Catalano; Giuseppe Musumeci; Guglielmo M Trovato
Journal:  EPMA J       Date:  2014-12-07       Impact factor: 6.543

6.  Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis.

Authors:  Rahul Sao; Wilbert S Aronow
Journal:  Arch Med Sci       Date:  2017-07-05       Impact factor: 3.318

7.  Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case-control study.

Authors:  Gian Luca Erre; Floriana Castagna; Assunta Sauchella; Pierluigi Meloni; Arduino Aleksander Mangoni; Giuseppina Farina; Richard Woodman; Maria Pina Dore; Gianpaolo Vidili
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-11-18       Impact factor: 5.346

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.